ŞAHİN, N. Et Al. 2018. The Significance of p53 and Estrogen Expression in Endometrial Hyperplasias and Endometrioid Carcinomas: How should we evaluate immunohistochemistry?. Clinical Oncology and Research , vol.1, no.1 , 2-4.

ŞAHİN, N., AKATLI, A. N., AKPOLAT, N., YILMAZ, E., İNCİ COŞKUN, E., KARABULUT DOĞAN, Ü., ... ÇOLAK, C.(2018). The Significance of p53 and Estrogen Expression in Endometrial Hyperplasias and Endometrioid Carcinomas: How should we evaluate immunohistochemistry?. Clinical Oncology and Research , vol.1, no.1, 2-4.

ŞAHİN, NURHAN Et Al. "The Significance of p53 and Estrogen Expression in Endometrial Hyperplasias and Endometrioid Carcinomas: How should we evaluate immunohistochemistry?," Clinical Oncology and Research , vol.1, no.1, 2-4, 2018

ŞAHİN, NURHAN Et Al. "The Significance of p53 and Estrogen Expression in Endometrial Hyperplasias and Endometrioid Carcinomas: How should we evaluate immunohistochemistry?." Clinical Oncology and Research , vol.1, no.1, pp.2-4, 2018

ŞAHİN, N. Et Al. (2018) . "The Significance of p53 and Estrogen Expression in Endometrial Hyperplasias and Endometrioid Carcinomas: How should we evaluate immunohistochemistry?." Clinical Oncology and Research , vol.1, no.1, pp.2-4.

@article{article, author={NURHAN ŞAHİN Et Al. }, title={The Significance of p53 and Estrogen Expression in Endometrial Hyperplasias and Endometrioid Carcinomas: How should we evaluate immunohistochemistry?}, journal={Clinical Oncology and Research}, year=2018, pages={2-4} }